CFDE Data Portal | Search SMIM2-AS1

	Label	Description
	SMIM2-AS1 associations Collection (Entity type)	Associations for SMIM2-AS1_associations
	SMIM2-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SMIM2-AS1 Gene (Entity type)	ENSG00000227258 - SMIM2 antisense RNA 1
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE189035 inositol 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE164529 tamoxifen 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE189035 inositol 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

SMIM2-AS1 associations

Associations for SMIM2-AS1_associations

SMIM2-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

SMIM2-AS1

ENSG00000227258 - SMIM2 antisense RNA 1

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

GSE199107 tryptophan 6 v 7 human up

A Gene Set from LINCS

GSE189035 inositol 2 v 4 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 5 human up

A Gene Set from LINCS

GSE119369 H10 inhibition 3 v 7 human dn

A Gene Set from LINCS

GSE164529 tamoxifen 0 v 1 human up

A Gene Set from LINCS

GSE189035 inositol 2 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.